PARP inhibitors in first-line of ovarian cancers

被引：0
|
作者：
Rodrigues, Manuel [1 ,2 ]
机构：
[1] DRUM, Equipe Labellisee Ligue Natl Canc, Inserm, U830, Paris, France
[2] PSL Res Univ, Inst Curie, Dept Oncol Med, Paris, France
来源：
BULLETIN DU CANCER | 2020年 / 107卷 / 01期
关键词：
D O I：
10.1016/j.bulcan.2019.10.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [41] PARP inhibitors in ovarian cancer
    Ledermann, J. A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 40 - 44
  • [42] PARP inhibitors in ovarian cancer
    Franzese, Elisena
    Centonze, Sara
    Diana, Anna
    Carlino, Francesca
    Guerrera, Luigi Pio
    Di Napoli, Marilena
    De Vita, Ferdinando
    Pignata, Sandro
    Ciardiello, Fortunato
    Orditura, Michele
    [J]. CANCER TREATMENT REVIEWS, 2019, 73 : 1 - 9
  • [43] Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy
    Smyth, E. C.
    Gambardella, V
    Cervantes, A.
    Fleitas, T.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (05) : 590 - 599
  • [44] First-line chemotherapy for ovarian cancer – the controversy continues
    S B Kaye
    [J]. British Journal of Cancer, 2002, 87 : 813 - 814
  • [45] The integration of docetaxel into first-line chemotherapy for ovarian cancer
    Kaye, SB
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 : 31 - 33
  • [46] PARP Inhibitors in Prostate and Urothelial Cancers
    Garje, Rohan
    Vaddepally, Raju Kumar
    Zakharia, Yousef
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] First-line treatment of ovarian cancer: Proof and promise
    Runowicz, CD
    [J]. GYNECOLOGIC ONCOLOGY ISSUES IN THE 8TH IGCS MEETING OF BUENOS AIRES, 2000, : 3 - 6
  • [48] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    [J]. ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [49] First-line chemotherapy for ovarian cancer - the controversy continues
    Kaye, SB
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 813 - 814
  • [50] Procedures after first-line treatment of ovarian cancer
    Thomssen, C
    [J]. ONKOLOGIE, 1999, 22 : 27 - 28
12345